Literature DB >> 21945518

Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.

Karin E Smedby1, Henrik Hjalgrim.   

Abstract

We aimed to give an overview of the descriptive epidemiology and etiology of mantle cell lymphoma (MCL) in the context of all non-Hodgkin lymphoma (NHL) and major NHL subtypes, based on available published reports. In retrospective case series, MCL cases represent between 2 and 10% of all NHL. Population-based studies of MCL incidence by basic demographic characteristics are limited to the past 15-20 years and to Europe and the US. In both regions, average incidence rates of approximately 0.5 cases per 100,000 person-years were reported, with a male-to-female ratio of 2.3-2.5:1, and a median age at diagnosis of close to 70 years. Some data suggest a possible increase in MCL incidence over the last two decades, but the observation may also reflect improved diagnostics. The causes of MCL are not known. Studies of potential risk factors of MCL are few and conducted primarily within the framework of all NHL. Moderate associations with MCL risk have been reported for Borrelia burgdorferi infection, family history of hematopoietic malignancies, and genetic variation in the interleukin-10 and tumor necrosis factor genes, but findings remain unconfirmed. Large multicenter studies are needed to address these and other factors in risk of MCL with sufficient statistical power in the future.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21945518     DOI: 10.1016/j.semcancer.2011.09.010

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  26 in total

Review 1.  Management of mantle cell lymphoma in the elderly: current and potential strategies.

Authors:  Marguerite Vignon; Marie-Dominique Venon; Olivier Hermine; Richard Delarue
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

2.  Racial differences in three major NHL subtypes: descriptive epidemiology.

Authors:  Yang Li; Yu Wang; Zhuoyue Wang; Danhui Yi; Shuangge Ma
Journal:  Cancer Epidemiol       Date:  2015-01-02       Impact factor: 2.984

Review 3.  Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells.

Authors:  Danielle Wallace; Patrick M Reagan
Journal:  Drugs       Date:  2021-03-30       Impact factor: 9.546

4.  Velcade (Bortezomib) Receives 2 New FDA Indications: For Retreatment of Patients with Multiple Myeloma and for First-Line Treatment of Patients with Mantle-Cell Lymphoma.

Authors:  Lisa Raedler
Journal:  Am Health Drug Benefits       Date:  2015-03

5.  Integrated analysis of 10 lymphoma datasets identifies E2F8 as a key regulator in Burkitt's lymphoma and mantle cell lymphoma.

Authors:  An-Ping Yang; Leyna G Liu; Min-Min Chen; Fang Liu; Hua You; Lian Liu; Hua Yang; Yang Xun; Jing Liu; Rui-Xue Wang; David D Brand; Dahai Liu; Song Guo Zheng; Wen-Xing Li
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 6.  Risk factors for etiology and prognosis of mantle cell lymphoma.

Authors:  Yu Wang; Shuangge Ma
Journal:  Expert Rev Hematol       Date:  2014-02-22       Impact factor: 2.929

7.  A new marker, SOX11, aids the diagnosis of mantle cell lymphoma in the prostate: A case report.

Authors:  Binghai Chen; Guangming Yin; Lujing Duan; Wanmeng Li; Xianzhen Jiang
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

8.  Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Karin E Smedby; Joshua N Sampson; Jennifer J Turner; Susan L Slager; Marc Maynadié; Eve Roman; Thomas M Habermann; Christopher R Flowers; Sonja I Berndt; Paige M Bracci; Henrik Hjalgrim; Dennis D Weisenburger; Lindsay M Morton
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

9.  The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.

Authors:  Yong-Qiao He; Jin-Hong Zhu; Shao-Yi Huang; Zhuo Cui; Jing He; Wei-Hua Jia
Journal:  Tumour Biol       Date:  2014-09-10

10.  Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.

Authors:  Jia-Jia Huang; Ya-Jun Li; Yi Xia; Yu Wang; Wen-Xiao Wei; Ying-Jie Zhu; Tong-Yu Lin; Hui-Qiang Huang; Wen-Qi Jiang; Zhi-Ming Li
Journal:  BMC Cancer       Date:  2013-05-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.